Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 81 Next >>

Filter Applied: steroid therapy,CNS treatment and complications with (Click to remove)

Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016

Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016

Treatment of Ocular Symptoms in Myasthenia Gravis
Neurol 71:1335-1341, Bhanushali,M.J.,et al, 2008

Evidence Report: The Medical Treatment of Ocular Myasthenia (An Evidence-Based Review)
Neurol 68:2144-2149, Benatar,M. &Kaminski,H.J., 2007

Immunosuppressive or Surgical Treatment for Ocular Myasthenia Gravis
Arch Neurol 64:1792-1794,1794, Chavis,P.S.,et al, 2007

Ocular Myasthenia Gravis Treatment: The Case Against Prednisone Therapy and Thymectomy
Arch Neurol 64:1790-1792,1794, Gilbert,M.E.,et al, 2007

Ocular Myasthenia: Diagnosis, Treatment and Pathogenesis
The Neurologist 12:231-239, Kusner,L.,et al, 2006

Treatment of Ocular Myasthenia
Arch Neurol 57:752-753, Kaminski,H.J.&Daroff,R.B., 2000

Treatment of Ocular Myasthenia With Corticosteroids
Arch Neurol 57:750-751,753, Agius,M.A., 2000

Beneficial Effects of Corticosteroids on Ocular Myasthenia Gravis
ARch Neurol 53:802-804, Kupersmith,M.J.,et al, 1996

Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994

Ocular Myasthenia:Diagnosis & Therapy
In Neuro-Ophthalmology, Vol X ed. by J. Glaser. CV Mosby Co, St. Louis, Daroff,R., 1980

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

A Randomized Controlled Trial of Methotrexate for Patients with Generalized Myasthenia Gravis
Neurol 87:57-64, Pasnoor, M.,et al, 2016

A Trial of Mycophenolate Mofetil With Prednisone as Initial Immunotherapy of Myasthenia Gravis
Neurol 71:394-399,390, The Muscle Study Group, 2008

An International, Phase III, Randomized Trial of Mycophenolate Mofetil in Myasthenia Gravis
Neurol 71:400-406, 390, Sanders,D.B.,et al., 2008

Immunosuppressant Drugs for Myasthenia Gravis
JNNP 80:5-6, Hart,I.K.,et al, 2008

Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004

Treatment of Autoimmune Myasthenia Gravis
Neurol 61:1652-1661, Richman,D.P. & Agius,M.A., 2003

Steroid Treatment for Myasthenia Gravis
Muscle Nerve 25:115-121, Rivner,M.H., 2002

A Randomized Double-Blind Trial of Prednisolone Alone or with Azathioprine in Myasthenia Gravis
Neurol 50:1778-1783, Palace,J.,et al, 1998

Treatment of Acquired Myasthenia Gravis
Neurol 48 (Suppl 5) :S46-S51997., Massey,J.M., 1997

Lambert-Eaton Myasthenic Syndrome:Clinical Diagnosis,Immune-Mediated Mechanisms,and Update on Therapies
Ann Neurol 37:S63-S73, Sanders,D.B., 1995

Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994

Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991

Prednisone-Induced Worsening of Neuromuscular Function in Myasthenia Gravis
Neurol 36:729-732, Miller,R.G.,et al, 1986

High-Dose Intravenous Methylprednisolone in Myasthenia Gravis
Arch Neurol 42:1149-1153, Arsura,E.,et al, 1985

Long-Term Corticosteroid Treatment of Myasthenia Gravis:Report of 116 Patients
Ann Neurol 15:291-298, Pascuzzi,R.M.,et al, 1984

Myasthenia Gravis:Prolonged Treatment with Steroids
Neurol 34:170-174, Sghirlanzoni,A.,et al, 1984

Eaton-Lambert Myasthenic Syndrome:Long-term Treatment of Three Patients with Prednisone
Ann Neurol 10:448-453, Streib,E.W.,et al, 1981

Humoral Immunity in Myasthenia Gravis:Effect of Steroids & Thymectomy
Neurol 30:554-557, Tindall,R.S.A., 1980

Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980

Prednisone Use in Concurrent Autoimmune Diseases
Arch Neurol 36:103-106, Harati,Y.,et al, 1979

Myasthenia Gravis
NEJM 298:136, Drachman,D.B., 1978

Effective Treatment of Infantile Myasthenia Gravis by Combined Prednisone & Thymectomy
Neurol 27:550, Sarnat,H.B.,et al, 1977

Clinical Pathological Conference
Giant-cell Arteritis of Temporal Artery (temporal arteritis) , Case Record 35-1977, NEJM 297:4927., , 1977

Plasmapheresis & Immunosuppressive Drug Therapy in Myasthenia Gravis
NEJM 297:1134, Dau,P.C.,et al, 1977

Long-term Administration of Corticosteroids in Myasthenia Gravis
Neurol 26:729, Mann,J.D.,et al, 1976

Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975

Gradually Increasing Doses of Prednisone in Myasthenia Gravis
NEJM 290:81, 1974. , 290:63174., Seybold,M.,et al, 1974

Benefit from Alternate-Day Prednisone in Myasthenia Gravis
NEJM 286:17, Warmolts,J.,et al, 1972

IgG4-Related Orbital Inflammation
https://EyeWiki.org, Oct, Chelnis,J. & Gervasio,K.A., 2023

Cases with IgG4-related Ophthalmic Disease with Mass Lesions Surrounding the Optic Nerve
Am J Ophthalmol 25:101324, Hamaoka, S.,t al, 2022

The Tolosa-Hunt Syndrome
NJJP 71:577-582, Kline,L.B. & Hoyt,W.F., 2021

Young Woman with Orbital Pain and Diplopia
Neurol 94:e752-e757, Infante, R.,et al, 2020

A 22-Year-Old Man with Progressive Bilateral Visual Loss
Neurol 94:625-630, Yang, S.L.,et al, 2020

Clinicopathologic Conference, Granulomatosis with Polyangiitis
NEJM 379:2452-2461, Case 39-2018, 2018

Overview of IgG4-related Disease
UptoDate, July, Moutsopoulos,H.,et al, 2017



Showing articles 0 to 50 of 81 Next >>